{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreif4mosrs4vk6zp7kl5ecdhmc4t2a3pzfto2cczlmbe3nquuuce63i",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkirb6b2hcc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigezhxs6dcuag76lez26znnyk3tpkmncfjco4mwat4h2f2ogwg5ui"
    },
    "mimeType": "image/jpeg",
    "size": 85322
  },
  "path": "/2026/04/27/ourka-psoriasis-inectable-treatment-study/?utm_campaign=rss",
  "publishedAt": "2026-04-27T11:00:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "chronic diseases",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical trial, its maker, Oruka Therapeutics, reported.",
  "title": "STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage study",
  "updatedAt": "2026-04-26T23:38:39.000Z"
}